Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432765 · ClinicalTrials.gov registry record · NA
AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function
A NA study, sponsored by University of Florida.
- Not yet
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05432765 is a NA study that has not yet begun recruiting, run by University of Florida. The registered enrollment target is 34 participants.
The verdict
NCT05432765, a NA study, has not yet begun recruiting, sponsored by University of Florida.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The objective of the proposed study it to perform a pilot clinical trial both to establish feasibility of applying a computational, augmented intelligence based approach, Phenotypic Precision Medicine (PPM), to optimizing combination drug therapy and to gather preliminary data to support a larger fully powered multi-center clinical trial. The key rationale for this clinical selection is that we have the technical, biological, and medical expertise in this disease, a wealth of experience in the use of PPM in both in vitro and the clinical setting, and a robust and integrated transplant program with a well-functioning clinical trial infrastructure.
Interventions
- OTHER Phenotypic Personalized Medicine Dosing
- OTHER Standard of Care Dosing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2026-12 |
| Est. Completion | 2031-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05432765
The ClinicalTrials.gov registry entry for NCT05432765 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phenotypic Personalized Medicine Dosing is the first listed.
NCT05432765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05432765 about?
NCT05432765 is a clinical study titled "AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function". The objective of the proposed study it to perform a pilot clinical trial both to establish feasibility of applying a computational, augmented intelligence based approach, Phenotypic Precision Medicine (PPM), to optimizing combination drug therapy and to gather preliminary data to support a larger fu...
What is the current status of trial NCT05432765?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2026-12. Estimated completion is 2031-01-01.
What interventions are being tested in trial NCT05432765?
The interventions under investigation include: Phenotypic Personalized Medicine Dosing (OTHER), Standard of Care Dosing (OTHER).
Who is sponsoring clinical trial NCT05432765?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.